- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Horphag Research
Total 40201 results
-
University of ArizonaHorphag ResearchTerminatedDiastolic Dysfunction | Cardiac FibrosisUnited States
-
OrphAI TherapeuticsRecruitingPulmonary HypertensionUnited States
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Orphan AustraliaCompleted
-
Orphan MedicalCompletedNarcolepsyUnited States, Canada, Switzerland
-
Swedish Orphan BiovitrumSuspendedCold Agglutinin DiseaseSpain, Belgium, Norway, United States, Japan, United Kingdom, Netherlands, Canada, Hungary, Austria, Finland, Georgia, Germany, Italy
-
Swedish Orphan BiovitrumActive, not recruitingPrimary Hemophagocytic LymphohistiocytosisChina
-
Swedish Orphan BiovitrumActive, not recruitingImmune Thrombocytopenia | ITPCroatia, Czechia, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
-
Swedish Orphan BiovitrumCompleted
-
Swedish Orphan BiovitrumCompleted
-
Swedish Orphan BiovitrumTerminatedStill's Disease, Adult-Onset | Still's Disease, Juvenile-OnsetUnited States, Canada
-
Swedish Orphan BiovitrumCompleted
-
Swedish Orphan BiovitrumCompletedHaemophilia A | Haemophilia BFrance, Germany, Italy, Spain, Sweden, Belgium, United Kingdom
-
Swedish Orphan BiovitrumCompletedEfficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1 (HT-1)Hereditary Tyrosinemia, Type IBelgium, Denmark, France, Germany, Sweden
-
Swedish Orphan BiovitrumTerminatedPrevention of Growth RestrictionBelgium, France, Germany, Hungary, Italy, Poland, Spain, Sweden, Czech Republic, Russian Federation
-
Swedish Orphan BiovitrumCompletedMultiple MyelomaGermany
-
Swedish Orphan BiovitrumCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma
-
Swedish Orphan BiovitrumCompleted
-
Swedish Orphan BiovitrumRecruitingHereditary Tyrosinemia, Type IChina
-
Swedish Orphan BiovitrumRecruitingSystemic Lupus Erythematosus | Macrophage Activation Syndrome | Still Disease | Secondary Hemophagocytic Lymphohistiocytosis | SJIA | AOSD | MASUnited States, Belgium, Italy, Netherlands, United Kingdom, China, France, Spain, Czechia, Canada, Sweden, Japan, Germany, Poland
-
Swedish Orphan BiovitrumActive, not recruitingHemophilia ASpain, Germany, Czechia, Italy, Estonia, Finland, Greece, Netherlands, Saudi Arabia, Slovenia, Sweden, Switzerland, United Kingdom
-
Swedish Orphan BiovitrumCompletedStudy to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic LymphohistiocytosisPrimary Hemophagocytic LymphohistiocytosisSpain, United States, United Kingdom, Germany, Italy, Sweden, Canada, Switzerland
-
Swedish Orphan BiovitrumCompletedHaemophilia A | Haemophilia BSweden, Finland, Denmark
-
Swedish Orphan BiovitrumCompletedHealthy VolunteersUnited Kingdom
-
Swedish Orphan BiovitrumCompletedHaemophilia A | Haemophilia BGermany
-
Swedish Orphan BiovitrumCompletedSanfilippo Syndrome Type A (MPS IIIA)United States, Turkey
-
Swedish Orphan BiovitrumCompletedSanfilippo Syndrome Type A (MPS IIIA)United States, Germany, Turkey
-
Swedish Orphan BiovitrumCompletedAcute Gouty ArthritisUnited States
-
Swedish Orphan BiovitrumCompletedHereditary Tyrosinemia, Type IBelgium, Denmark, France, Germany, Austria, Czechia, Finland, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
-
Swedish Orphan BiovitrumCompletedStill Disease, Juvenile OnsetItaly
-
Swedish Orphan BiovitrumCompleted
-
Swedish Orphan BiovitrumCompleted
-
Swedish Orphan BiovitrumCompletedReplacement Therapy in Preterm InfantsFrance, Italy
-
Orpha LabsUnknownGlycogen Storage Disease, Type 14Turkey
-
Swedish Orphan BiovitrumRecruitingStill's Disease, Adult-Onset | Macrophage Activation Syndrome | Stills Disease, Juvenile-OnsetUnited States, Canada, France, Germany, Italy, Netherlands, Spain
-
Swedish Orphan BiovitrumRecruitingParoxysmal Nocturnal HemoglobinuriaSpain
-
Swedish Orphan BiovitrumCompletedChronic GoutUnited States
-
Swedish Orphan BiovitrumCompletedChronic GoutUnited States, Serbia, Georgia, Ukraine, Russian Federation
-
Swedish Orphan BiovitrumCompletedArthritis, Juvenile | Lymphohistiocytosis, Hemophagocytic | Macrophage Activation Syndrome | Adult Onset Still DiseaseUnited States, Spain, United Kingdom, France, Italy
-
Swedish Orphan BiovitrumTerminated
-
Swedish Orphan BiovitrumCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyNetherlands, Poland
-
Swedish Orphan BiovitrumCompletedHereditary Tyrosinemia, Type IGermany, United Kingdom, France
-
Swedish Orphan BiovitrumCompletedDiabetic Neuropathic PainCzech Republic, Germany, South Africa
-
Swedish Orphan BiovitrumCompletedReplacement Therapy in Preterm InfantsItaly
-
Swedish Orphan BiovitrumCompletedFocus: BioavailabilitySweden
-
Orpha LabsCompletedLeukocyte Adhesion Deficiency, Type II
-
AOP Orphan Pharmaceuticals AGNot yet recruitingPulmonary Arterial HypertensionSpain, Austria, France, Hungary